A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer Kumiko KidaAkimitsu YamadaTakashi Ishikawa Original Article 08 March 2024 Pages: 409 - 416
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan Yasue TsuchidaNaoki NiikuraNaoki Hayashi Original Article 07 March 2024 Pages: 401 - 408
Deep learning model to predict Ki-67 expression of breast cancer using digital breast tomosynthesis Ken ObaMaki AdachiHiroko Tsunoda Special Feature 07 March 2024
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Reiko FukuiTakahiro WatanabeYasuo Miyoshi Letter to the Editor 04 March 2024 Pages: 536 - 538
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines Masaya HattoriNaoko HonmaYutaka Yamamoto Special Article Open access 04 March 2024 Pages: 335 - 339
SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β Monalisa ParijaSurya PrakashSandip K. Mishra Original Article 29 February 2024 Pages: 440 - 455
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Nalee KimWon Kyung ChoHaeyoung Kim Original Article 18 February 2024 Pages: 391 - 400
Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer Kazuhiko SatoHiromi FuchikamiMasahiro Kato Original Article 15 February 2024 Pages: 382 - 390
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer Sean M. HackingGabrielle WindsorYihong Wang Rapid Communication 13 February 2024 Pages: 529 - 535
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy Mikiko KasaharaSayaka KanematsuMasahiro Watatani Original Article 07 February 2024 Pages: 329 - 334
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry Takayuki IwamotoHiraku KumamaruShigehira Saji Special Article 06 February 2024 Pages: 185 - 194
Advances in the study of autophagy in breast cancer Tang YuLiu RuiHu Ying Review Article Open access 05 February 2024 Pages: 195 - 204
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer Jie-Yin ZhuangZe-Nan HuangMin Dong Original Article 04 February 2024 Pages: 317 - 328
Patient-reported outcomes of mesh in minimally invasive (laparoscopic/robot-assisted) immediate subpectoral prosthesis breast reconstruction: a retrospective study Xin WuYu GuiLi Chen Original Article 02 February 2024 Pages: 243 - 251
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models Hongyan ZhengLihua WuGe Lou Original Article 30 January 2024 Pages: 371 - 381
Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer Nobuhiro HoshiTakefumi UemuraSatoshi Waguri Original Article Open access 24 January 2024 Pages: 305 - 316
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes Wu DingDengfeng YeChuanjian Tu Original Article 17 January 2024 Pages: 295 - 304
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan Yasuaki SagaraHiraku KumamaruShigehira Saji Special Article 05 January 2024 Pages: 179 - 184
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy Naruto TairaYuichiro KikawaMasataka Sawaki Original Article 04 January 2024 Pages: 283 - 294
The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience Yi-Wen HongI-Ming KuoHsu-Huan Chou Original Article Open access 27 December 2023 Pages: 252 - 262
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre Han Hsi WongElena CojocaruHelen Hatcher Original Article 26 December 2023 Pages: 272 - 282
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition Masaaki KawaiShoichiro OhtaniShigehira Saji Special Article Open access 26 December 2023 Pages: 166 - 178
Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence Fatemeh KazemzadehJ. A. A. SnoekIris D. Nagtegaal Original Article 22 December 2023 Pages: 263 - 271
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale Yosuke AoyamaEri HoshinoHidetaka Kawabata Original Article 11 December 2023 Pages: 234 - 242
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition Kazunori KubotaKazutaka NakashimaAkihiko Suzuki Correction Open access 11 December 2023 Pages: 165 - 165
Are breast cancer subtypes different in breast cancer patients with and without hepatitis C virus infection? Kadri Altundag Letter to the Editor 09 December 2023 Pages: 155 - 155
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan Bo-Fang ChenYi-Fang TsaiChi-Cheng Huang Original Article 09 December 2023 Pages: 217 - 227
Annual report of the Japanese Breast Cancer Registry for 2019 Minoru MiyashitaHiraku KumamaruShigehira Saji Special Article 04 December 2023 Pages: 16 - 23
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database Zhenning TangLing LiLingyan Huang Original Article 03 December 2023 Pages: 205 - 216
The effects of breast density on the benefits of mammograms with adjunctive ultrasonography in breast screening Akira NakamuraKoji OhnukiAtsushi Kano Original Article 28 November 2023 Pages: 228 - 233
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer Asumi IesatoAtsushi FushimiNami Yamashita Original Article Open access 23 November 2023 Pages: 63 - 74
Comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Yoshiya Horimoto Letter to the Editor 20 November 2023 Pages: 154 - 154
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan Yoshitaka NishikawaNobukazu AgatsumaTakeo Nakayama Original Article Open access 20 November 2023 Pages: 105 - 115
IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G Rui JingShukun BaiGuoxu Zheng Original Article Open access 19 November 2023 Pages: 135 - 147
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels Amira FathyMohamed A. AbdelrazekMohamed El-Far Original Article Open access 16 November 2023 Pages: 116 - 123
The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition Kazunori KubotaKazutaka NakashimaAkihiko Suzuki Special Article Open access 16 November 2023 Pages: 157 - 164
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study Florian PelzerWilfried TrögerDaniela Paepke Original Article Open access 15 November 2023 Pages: 124 - 134
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer Helle PappotBenóný P. BjörnssonCecilie Holländer-Mieritz Rapid Communication 08 November 2023 Pages: 148 - 153
The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition Naoko HonmaMasayuki YoshidaShigehira Saji Special Article Open access 07 November 2023 Pages: 8 - 15
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer Xiaowei ShenGanggang WangWeixing Shen Original Article 02 November 2023 Pages: 96 - 104
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy Mellissa WilliamsonDavid J. PressKaustubh Gururaj Original Article Open access 01 November 2023 Pages: 84 - 95
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole Masato TakahashiTomofumi OsakoNorikazu Masuda Original Article Open access 26 October 2023 Pages: 53 - 62
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study Masahiro YoshidaRyo-ichi YoshimuraWorking group of APBI with SAVIs in Japan (WASAVIs) Original Article 21 October 2023 Pages: 75 - 83
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition Takehiko SakaiGoro KutomiShigehira Saji Special Article 16 October 2023 Pages: 1 - 7
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study Linghui KongZhen YangHuijun Zhang Original Article 13 October 2023 Pages: 42 - 52
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography Takayoshi Uematsu Review Article Open access 12 October 2023 Pages: 24 - 30
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer Yoshitaka FujikiMasahiro KashiwabaYasuaki Sagara Original Article Open access 09 October 2023 Pages: 31 - 41
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition Mitsuo TeradaAki ItoTatsuya Toyama Special Article Open access 07 October 2023 Pages: 872 - 884
Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer Kazushi SuzukiRintaro OheMitsuru Futakuchi Original Article Open access 04 October 2023 Pages: 1094 - 1104
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer Hiroki KusamaNobuyoshi KittakaTakahiro Nakayama Original Article 02 October 2023 Pages: 1085 - 1093
